Isatuximab in the treatment of refractory and relapsed multiple myeloma: literature review and case report

Multiple myeloma is a malignant tumor characterized by the proliferation of clonal plasma cells and currently remains an incurable disease, despite advances in therapy. Resistance and development of double refractoriness represent a significant problem, worsening the prognosis. To overcome double re...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu. E. Ryabukhina, P. A. Zeynalova, F. M. Abbasbeyli, O. L. Timofeeva, T. T. Valiev, N. A. Kupryshina, A. G. Zhukov
Format: Article
Language:Russian
Published: ABV-press 2023-12-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/871
Tags: Add Tag
No Tags, Be the first to tag this record!